{
  "analyses": [
    {
      "symbol": "SRRK",
      "approved": true,
      "consensus_score": 7.08,
      "agent_scores": {
        "fundamental": 7.5,
        "technical": 6.8,
        "news": 8.0,
        "sentiment": 7,
        "bull": 7.8,
        "bear": 5.5,
        "risk": 6.5
      },
      "position_size_pct": 3,
      "position_size_shares": 96,
      "current_price": 32.18,
      "stop_price": 27.35,
      "target_price": 45,
      "catalyst": "FDA PDUFA Sept 22 - apitegromab approval"
    },
    {
      "symbol": "INCY",
      "approved": true,
      "consensus_score": 7.88,
      "agent_scores": {
        "fundamental": 8.5,
        "technical": 7.8,
        "news": 9.0,
        "sentiment": 8,
        "bull": 8.8,
        "bear": 5,
        "risk": 8
      },
      "position_size_pct": 5,
      "position_size_shares": 61,
      "current_price": 83.97,
      "stop_price": 80.61,
      "target_price": 92,
      "catalyst": "FDA PDUFA Sept 19 - Opzelura pediatric expansion"
    },
    {
      "symbol": "CBRL",
      "approved": true,
      "consensus_score": 7.08,
      "agent_scores": {
        "fundamental": 7.5,
        "technical": 6.8,
        "news": 8.0,
        "sentiment": 7,
        "bull": 7.8,
        "bear": 5.5,
        "risk": 6.5
      },
      "position_size_pct": 4,
      "position_size_shares": 81,
      "current_price": 51.0,
      "stop_price": 46.92,
      "target_price": 60,
      "catalyst": "Q4 Earnings Sept 17 AMC - short squeeze setup (34% SI)"
    },
    {
      "symbol": "PASG",
      "approved": false,
      "consensus_score": 6.28,
      "agent_scores": {
        "fundamental": 6.5,
        "technical": 5.8,
        "news": 7.0,
        "sentiment": 6,
        "bull": 6.8,
        "bear": 6,
        "risk": 5
      },
      "position_size_pct": 2,
      "position_size_shares": 300,
      "current_price": 6.91,
      "stop_price": 5.53,
      "target_price": 10,
      "catalyst": "Insider buying + Q4 clinical data FTD gene therapy"
    },
    {
      "symbol": "RIVN",
      "approved": true,
      "consensus_score": 7.88,
      "agent_scores": {
        "fundamental": 8.5,
        "technical": 7.8,
        "news": 9.0,
        "sentiment": 8,
        "bull": 8.8,
        "bear": 5,
        "risk": 8
      },
      "position_size_pct": 5,
      "position_size_shares": 357,
      "current_price": 14.5,
      "stop_price": 12.69,
      "target_price": 15,
      "catalyst": "Q3 deliveries early October - peak quarter expected"
    }
  ],
  "executed": [
    {
      "order_id": "3212ff0f-e10d-4fea-b75d-3a6b55d65a17",
      "symbol": "INCY",
      "qty": 61,
      "side": "buy",
      "status": "submitted"
    },
    {
      "order_id": "6b7110a9-752c-4e8d-8c1e-02bb2a3b1c1b",
      "symbol": "CBRL",
      "qty": 81,
      "side": "buy",
      "status": "submitted"
    },
    {
      "order_id": "1c7e1944-6991-4be2-b845-4593f5d72ab9",
      "symbol": "RIVN",
      "qty": 357,
      "side": "buy",
      "status": "submitted"
    }
  ],
  "rejected": [
    "SRRK",
    "PASG"
  ]
}